Invesco Ltd. Gritstone Bio, Inc. Transaction History

Invesco Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.96 - $2.9 $20,485 - $30,310	-10,452 Reduced 15.96%	55,033 $141,000
Q4 2023 Feb 12, 2024	BUY	$1.28 - $2.85 $15,242 - $33,937	11,908 Added 22.23%	65,485 $133,000
Q3 2023 Nov 13, 2023	BUY	$1.19 - $2.26 $1,013 - $1,925	852 Added 1.62%	53,577 $92,000
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.03 $87,523 - $159,756	52,725 New	52,725 $102,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $24,576 - $60,260	-13,885 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $2.94 Million - $8.91 Million	-730,715 Reduced 98.14%	13,885 $57,000
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $2.91 Million - $4.55 Million	331,662 Added 80.32%	744,600 $9.58 Million
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $1.34 Million - $2.82 Million	208,516 Added 102.0%	412,938 $4.46 Million
Q2 2021 Aug 17, 2021	BUY	$8.13 - $10.2 $1.66 Million - $2.09 Million	204,422 New	204,422 $1.87 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.